Crystalys Therapeutics is a Biotech company based in San Diego. It has raised $205M in total funding. Latest round: Series A.
Crystalys Therapeutics is a Biotech company based in San Diego. Crystalys Therapeutics has raised $205M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in September 2025. The round record for Crystalys Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Novo Holdings, SR One, Catalys Pacific, Perceptive Xontogeny Venture Funds, Lightstone Ventures, AN Venture Partners and 7 others. 13 distinct backers are named across the disclosed rounds.
Round data for Crystalys Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in San Diego and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026